1. Home
  2. PGEN vs AVAH Comparison

PGEN vs AVAH Comparison

Compare PGEN & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.24

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$7.37

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
AVAH
Founded
1998
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
PGEN
AVAH
Price
$4.24
$7.37
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$8.33
$9.75
AVG Volume (30 Days)
3.0M
1.4M
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1850.00
EPS
N/A
0.19
Revenue
$230,981,000.00
$2,433,199,000.00
Revenue This Year
$1,115.92
$7.31
Revenue Next Year
$81.04
$5.59
P/E Ratio
N/A
$40.37
Revenue Growth
N/A
20.19
52 Week Low
$1.28
$3.73
52 Week High
$5.47
$10.32

Technical Indicators

Market Signals
Indicator
PGEN
AVAH
Relative Strength Index (RSI) 52.41 57.10
Support Level $3.97 $6.18
Resistance Level $4.40 $7.52
Average True Range (ATR) 0.25 0.36
MACD -0.01 0.08
Stochastic Oscillator 30.98 54.87

Price Performance

Historical Comparison
PGEN
AVAH

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.

Share on Social Networks: